XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial

BACKGROUND: Thin strut 3rd generation drug eluting stents offer the potential advantage over the previous generation of better technical performance and reduced neointimal proliferation parameters, which are linked to mid and late term device failure. AIM: To evaluate the performance of the Xlimus s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Cardiol Heart Vasc
Glavni autori: Testa, Luca, Pero, Gaetano, Bollati, Mario, Casenghi, Matteo, Popolo Rubbio, Antonio, Cuman, Magdalena, Moreno, Raul, Serra, Antoni, Gomez, Joan Antoni, Bedogni, Francesco
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487315/
https://ncbi.nlm.nih.gov/pubmed/31061876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2019.100363
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items